Invention Grant
- Patent Title: Anti-GPNMB antibodies and diagnostic uses thereof
-
Application No.: US15920367Application Date: 2018-03-13
-
Publication No.: US11002738B2Publication Date: 2021-05-11
- Inventor: Yifei Zhu , Zhiming Liao , Fernando Jose Rebelo do Couto
- Applicant: Spring BioScience Corporation
- Applicant Address: US CA Pleasanton
- Assignee: Spring BioScience Corporation
- Current Assignee: Spring BioScience Corporation
- Current Assignee Address: US CA Pleasanton
- Agency: Ventana Medical Systems, Inc.
- Main IPC: G01N33/574
- IPC: G01N33/574 ; C07K16/30 ; C07K16/28 ; G01N33/68
Abstract:
The present application discloses anti-GPNMB antibodies and methods of using the same. The antibodies are selected to bind to an epitope located in a C-terminal fragment of the protein and are selected for specificity in immunohistochemical assays. The antibodies are useful in, for example, immunohistochemical methods of detecting GPNMB-positive cells in tumors.
Public/Granted literature
- US20180208655A1 ANTI-GPNMB ANTIBODIES AND DIAGNOSTIC USES THEREOF Public/Granted day:2018-07-26
Information query
IPC分类:
